Corticosteroid Administration Does Not Affect Viral Oncolytic Activity, but Inhibits Antitumor Immunity in ReplicationCompetent Herpes Simplex Virus Tumor Therapy-Reference-Cited by-同舟云学术

Corticosteroid Administration Does Not Affect Viral Oncolytic Activity, but Inhibits Antitumor Immunity in ReplicationCompetent Herpes Simplex Virus Tumor Therapy

Published:1999-11-20 Issue:17 Volume:10 Page:2869-2878
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Todo Tomoki,Rabkin Samuel D.,Chahlavi Ali,Martuza Robert L.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430349950016591

Reference44 articles.

1. Neurotransmitter Synthesis by Neuroblastoma Clones

2. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

3. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide

4. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

5. Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in gene therapy for high-grade glioma: a review of the clinical evidence;Expert Review of Neurotherapeutics;2024-08

2. Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma;Cancers;2023-08-28

3. Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial;Nature Medicine;2022-07-21

4. A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma;Nature Communications;2022-07-21

5. The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review;Neuro-Oncology Advances;2022-01-01